Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
amgen
boston blog main
inclisiran
4
×
life sciences
national blog main
new york blog main
new york top stories
regeneron pharmaceuticals
4
×
boston top stories
cholesterol
clinical trials
national top stories
new york
praluent
repatha
alirocumab
alnylam pharmaceuticals
biotech
evolocumab
heart attack
ldl
medicines co.
mt sinai hospital
pcsk9
pcsk9 inhibitors
prashant vaishnava
san francisco blog main
san francisco top stories
sanofi
stroke
the medicines co.
boulder/denver blog main
boulder/denver top stories
cardiac
cardiovascular
cause of death
cedar-sinai
circulation
clinical studies
data
What
cholesterol
drug
lowering
4
×
medco
medicines
new
twice
aces
alnylam
announced
based
big
bringing
ceo
clears
closer
data
drugs
evidence
expensive
faces
fda
filing
financial
flexible
foe
healthcare
heart
hint
inched
inclisiran
inhibitors
key
known
lasting
long
looms
market
meant
medicine
Language
unset
Current search:
inclisiran
×
" regeneron pharmaceuticals "
×
lowering
×
photo
×
@xconomy.com
5 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
5 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms